Targeting protein-protein interactions (PPIs): Identifying PPI inhibitors for novel therapeutics
Dr. David Andrews, AstraZeneca, discusses the future of small-molecule drug discovery for PPIs
Dr. David Andrews, AstraZeneca, discusses the future of small-molecule drug discovery for PPIs
Watch world-leading scientists online, May 11-12, to discover the latest tools and techniques advancing COVID-19 research, immunotherapy development, drug screening, cancer diagnostics and more
OCREVUS significantly slowed loss of brain tissue within T2 MRI lesions in primary progressive multiple sclerosis (PPMS) in post-hoc analysis of Phase III ORATORIO study
The BinaxNOW Self-Test will be sold in 2-count packs for an MSRP of $23.99, making it an affordable over-the-counter COVID-19 rapid test available in the U.S.
The ZEISS Axioscan 7 combines scanning performance with application freedom
Watch this on-demand webinar to learn about the mechanisms behind cancer treatments such as CAR-T cells, checkpoint inhibitors or adoptive T cell therapy
Reserve your place today for talks on topics ranging from food fraud, spatial infiltration and CRISPR to antibody and AAV gene therapies
Guest editorial by Kim James, Solid Form Expert, LGC Drug Development Solutions
Scientists reveal that Coffea stenophylla – a rare and threatened species from West Africa – has the potential to ensure the future of great-tasting coffee under climate change
Dr. Veronica Gil discusses how 3D cell culture is enabling scientists to develop and craft organ-specific tissues from stem cells to transform prostate cancer therapy
The modular, automated 3D cell culture and image analysis lab enables customers to streamline and scale organoid interrogation, advancing drug discovery research
JEOL and SOQUELEC have a long relationship dating back to the 1970s